Study of the Prevalence of Iron Deficiency in Patients With Heart Failure

Heart Failure Clinical Trial

— CARENFER IC  

Official title:

Study of the Prevalence of Iron Deficiency in Patients With Heart Failure

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03924258
• Other study ID #: CARENFER IC
• Status: Not yet recruiting
• Phase: N/A
• Start date: May 15, 2019
• Est. completion date: June 30, 2019

Study information

• Verified date: April 2019
• Source: VIFORFRANCE
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Despite its known prevalence in Heart Failure, a recent study conducted by Prof. Cacoub (unpublished) on the French national health insurance database showed that iron deficiency was a poorly diagnosed and poorly treated comorbidity. In chronic diseases including Heart Failure, Transferrin Saturation Factor is only performed in about 10% of cases while it is recommended for patients with Heart Failure (French Health High Authority 2011). The purpose of this study is to obtain current data on the prevalence of iron deficiency in France in patients with Heart Failure, applying the recommendations of European Society of Cardiology and French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 1300
• Est. completion date: June 30, 2019
• Est. primary completion date: June 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient, male or female, over 18 years of age

• Patient present at the hospital on the day of the study

• Diagnosis of Heart Failure (acute or chronic) regardless of left ventricular ejection fraction (LVEF)

• Patient with signed consent

Exclusion Criteria:

• Protected patient: major under guardianship, tutorship or other legal protection, deprived of liberty by judicial or administrative decision

• Pregnant or breastfeeding woman

Related Conditions & MeSH terms

• Anemia, Iron-Deficiency
• Heart Failure

Intervention

Diagnostic Test:
• Iron status testing
Blood sample for iron status testing

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
VIFORFRANCE

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Complete blood iron status	ferritin, Transferrin Saturation Factor	One day